Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?

To: Robert DeHaven who wrote (408)	5/11/1998 10:20:00 PM
From: Manny Gugliuzza	Respond to of 1510

and do not forget about gruntal & co. with david saks are still aggressively following in their morning notes on a regular basis about Imnrs potential blockbuster drug-REMUNE. i think it was Dec. they upgraded the stock and have been regular with research reports, $10. each, nearly 2x a month. strong bids and good support intraday on pulls backs may just have to dive into those 15's at the market. ar.